CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-07 | KIM PAUL CFO and Treasurer | Grant or award | +77,585 | 225,852 | ||
| 2022-11-07 | Hsieh Ming Chief Executive Officer | Grant or award | +566,171 | $39.02 | $22.1M | 596,171 |
| 2022-11-07 | Hsieh Ming Chief Executive Officer | Grant or award | +220,816 | $39.02 | $8.6M | 220,816 |
| 2022-11-07 | Xie Jian President and COO | Grant or award | +129,309 | 432,065 | ||
| 2022-11-07 | Xie Jian President and COO | Grant or award | +220,816 | 220,816 | ||
| 2022-11-07 | Gao Hanlin Chief Scientific Officer | Grant or award | +51,723 | 906,927 | ||
| 2022-11-03 | Xie Jian President and COO | Shares withheld for taxes | −6,198 | $37.89 | $235K | 302,756 |
| 2022-11-03 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −1,240 | $37.89 | $47K | 148,267 |
| 2022-11-01 | Xie Jian President and COO | Shares withheld for taxes | −775 | $40.25 | $31K | 308,954 |
| 2022-10-30 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −76 | $40.28 | $3K | 855,204 |
| 2022-09-14 | Hsieh Ming Chief Executive Officer | Other acquisition · Forward sale contract (obligation to sell) | +800,000 | 800,000 | ||
| 2022-09-06 | KIM PAUL CFO and Treasurer | Sale | −662 | $41.39 | $27K | 149,507 |
| 2022-08-30 | Xie Jian President and COO | Sale | −675 | $44.18 | $30K | 309,729 |
| 2022-08-17 | Xie Jian President and COO | Sale | −1,414 | $48.89 | $69K | 310,404 |
| 2022-08-17 | KIM PAUL CFO and Treasurer | Sale | −1,945 | $48.89 | $95K | 150,169 |
| 2022-08-17 | Gao Hanlin Chief Scientific Officer | Sale | −370 | $48.89 | $18K | 855,280 |
| 2022-08-03 | Xie Jian President and COO | Shares withheld for taxes | −6,343 | $62.93 | $399K | 311,818 |
| 2022-08-03 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −1,048 | $62.93 | $66K | 152,114 |
| 2022-08-01 | Nohaile Michael Director | Grant or award | +4,000 | 4,000 | ||
| 2022-08-01 | Nohaile Michael Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 18 of 23 · 453 trades